Fig. 1
From: Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival
Cell Viability of AGS R-CDDP cells exposed to MVC and/or CDDP. Cells were incubated with MVC and/or CDDP for 24, 48, and 72 h, and cell viability was measured using a standard viability assay (MTT). Two-way ANOVA with Bonferroni post-hoc test was used to compare the groups. Values of P ≤ 0.05 were considered statistically significant. *P ≤ 0.05, ***P < 0.001 and ***P < 0.0001. Data were expressed as mean ± SD of three biological replicates. Maraviroc (MVC) and Cisplatin (CDDP)